Janux Therapeutics (JANX) Leases: 2021-2025
Historic Leases for Janux Therapeutics (JANX) over the last 4 years, with Sep 2025 value amounting to $18.9 million.
- Janux Therapeutics' Leases fell 3.88% to $18.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.9 million, marking a year-over-year decrease of 3.88%. This contributed to the annual value of $19.3 million for FY2024, which is 7.45% down from last year.
- Per Janux Therapeutics' latest filing, its Leases stood at $18.9 million for Q3 2025, which was up 2.50% from $18.5 million recorded in Q2 2025.
- In the past 5 years, Janux Therapeutics' Leases registered a high of $22.8 million during Q2 2022, and its lowest value of $130,000 during Q1 2022.
- Over the past 3 years, Janux Therapeutics' median Leases value was $20.1 million (recorded in 2024), while the average stood at $20.1 million.
- Per our database at Business Quant, Janux Therapeutics' Leases surged by 16,766.92% in 2023 and then declined by 8.04% in 2025.
- Janux Therapeutics' Leases (Quarterly) stood at $185,000 in 2021, then soared by 11,942.70% to $22.3 million in 2022, then decreased by 6.47% to $20.8 million in 2023, then declined by 7.45% to $19.3 million in 2024, then dropped by 3.88% to $18.9 million in 2025.
- Its Leases was $18.9 million in Q3 2025, compared to $18.5 million in Q2 2025 and $18.9 million in Q1 2025.